Corvus hawaiiensis isolate bCorHaw1 chromosome 30, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036375.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
protein tyrosine phosphatase non-receptor type 3, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
protein tyrosine phosphatase non-receptor type 3, transcript variant X1
protein tyrosine phosphatase non-receptor type 3, transcript variant X3
protein tyrosine phosphatase non-receptor type 3, transcript variant X4
tyrosine-protein phosphatase non-receptor type 3 isoform X2
tyrosine-protein phosphatase non-receptor type 3 isoform X1
tyrosine-protein phosphatase non-receptor type 3 isoform X3
tyrosine-protein phosphatase non-receptor type 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
molybdenum cofactor sulfurase, transcript variant X1
molybdenum cofactor sulfurase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
molybdenum cofactor sulfurase, transcript variant X4
molybdenum cofactor sulfurase, transcript variant X2
poly(rC)-binding protein 3-like, transcript variant X13
poly(rC)-binding protein 3-like, transcript variant X16
poly(rC)-binding protein 3-like, transcript variant X17
poly(rC)-binding protein 3-like, transcript variant X18
poly(rC)-binding protein 3-like, transcript variant X14
poly(rC)-binding protein 3-like, transcript variant X15
poly(rC)-binding protein 3-like, transcript variant X2
poly(rC)-binding protein 3-like, transcript variant X6
poly(rC)-binding protein 3-like, transcript variant X3
poly(rC)-binding protein 3-like, transcript variant X1
poly(rC)-binding protein 3-like, transcript variant X9
poly(rC)-binding protein 3-like, transcript variant X10
poly(rC)-binding protein 3-like, transcript variant X5
poly(rC)-binding protein 3-like, transcript variant X11
poly(rC)-binding protein 3-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
poly(rC)-binding protein 3-like, transcript variant X19
poly(rC)-binding protein 3-like, transcript variant X7
poly(rC)-binding protein 3-like, transcript variant X4
poly(rC)-binding protein 3-like, transcript variant X8
poly(rC)-binding protein 3-like isoform X10
poly(rC)-binding protein 3-like isoform X6
poly(rC)-binding protein 3-like isoform X11
poly(rC)-binding protein 3-like isoform X9
poly(rC)-binding protein 3-like isoform X7
poly(rC)-binding protein 3-like isoform X8
poly(rC)-binding protein 3-like isoform X1
poly(rC)-binding protein 3-like isoform X2
poly(rC)-binding protein 3-like isoform X3
poly(rC)-binding protein 3-like isoform X4
poly(rC)-binding protein 3-like isoform X5
poly(rC)-binding protein 3-like isoform X12
BAG cochaperone 1, transcript variant X2
BAG cochaperone 1, transcript variant X1
BAG family molecular chaperone regulator 1 isoform X2
BAG family molecular chaperone regulator 1 isoform X1
succinate dehydrogenase complex flavoprotein subunit A
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
coiled-coil domain containing 127, transcript variant X1
coiled-coil domain containing 127, transcript variant X2
coiled-coil domain-containing protein 127 isoform X1
coiled-coil domain containing 127, transcript variant X3
coiled-coil domain-containing protein 127 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent neutral amino acid transporter B(0)AT1
sodium-dependent neutral amino acid transporter B(0)AT3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
cleft lip and palate transmembrane protein 1-like protein
lysophosphatidylcholine acyltransferase 1, transcript variant X3
lysophosphatidylcholine acyltransferase 1, transcript variant X2
lysophosphatidylcholine acyltransferase 1, transcript variant X1
lysophosphatidylcholine acyltransferase 1, transcript variant X4
lysophosphatidylcholine acyltransferase 1 isoform X2
lysophosphatidylcholine acyltransferase 1 isoform X1
lysophosphatidylcholine acyltransferase 1 isoform X4
lysophosphatidylcholine acyltransferase 1 isoform X3
mitochondrial ribosomal protein L36, transcript variant X2
mitochondrial ribosomal protein L36, transcript variant X1
39S ribosomal protein L36, mitochondrial
NADH:ubiquinone oxidoreductase subunit S6
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
iroquois homeobox 4, transcript variant X5
iroquois homeobox 4, transcript variant X2
iroquois homeobox 4, transcript variant X8
iroquois homeobox 4, transcript variant X1
iroquois homeobox 4, transcript variant X4
iroquois homeobox 4, transcript variant X3
iroquois homeobox 4, transcript variant X6
iroquois homeobox 4, transcript variant X7
iroquois-class homeodomain protein IRX-4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-2
uncharacterized LOC125318439, transcript variant X3
uncharacterized LOC125318439, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125318439, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC125318439 isoform X2
uncharacterized protein LOC125318439 isoform X1
iroquois homeobox 1, transcript variant X2
iroquois homeobox 1, transcript variant X1
iroquois-class homeodomain protein IRX-1
ankyrin repeat and sterile alpha motif domain containing 6, transcript variant X1
ankyrin repeat and sterile alpha motif domain containing 6, transcript variant X4
ankyrin repeat and sterile alpha motif domain containing 6, transcript variant X3
ankyrin repeat and sterile alpha motif domain containing 6, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 6, transcript variant X5
ankyrin repeat and SAM domain-containing protein 6 isoform X1
ankyrin repeat and SAM domain-containing protein 6 isoform X2
polypeptide N-acetylgalactosaminyltransferase 12, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 12, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 12 isoform X1
polypeptide N-acetylgalactosaminyltransferase 12 isoform X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
elongator acetyltransferase complex subunit 2, transcript variant X2
elongator acetyltransferase complex subunit 2, transcript variant X1
catenin alpha like 1, transcript variant X1
catenin alpha like 1, transcript variant X3
catenin alpha like 1, transcript variant X2
transmembrane protein with EGF like and two follistatin like domains 1, transcript variant X3
transmembrane protein with EGF like and two follistatin like domains 1, transcript variant X2
transmembrane protein with EGF like and two follistatin like domains 1, transcript variant X1
exocyst complex component 3, transcript variant X2
exocyst complex component 3, transcript variant X1
programmed cell death 6, transcript variant X1
programmed cell death 6, transcript variant X2
programmed cell death protein 6 isoform X1
programmed cell death protein 6 isoform X2
uncharacterized LOC125318493, transcript variant X2
uncharacterized LOC125318493, transcript variant X1
uncharacterized LOC125318493, transcript variant X5
uncharacterized LOC125318493, transcript variant X7
uncharacterized LOC125318493, transcript variant X4
uncharacterized LOC125318493, transcript variant X6
uncharacterized LOC125318493, transcript variant X3
uncharacterized protein LOC125318493 isoform X2
uncharacterized protein LOC125318493 isoform X1
uncharacterized protein LOC125318493 isoform X4
uncharacterized protein LOC125318493 isoform X3
uncharacterized protein LOC125318493 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Myb/SANT DNA binding domain containing 3, transcript variant X6
Myb/SANT DNA binding domain containing 3, transcript variant X5
Myb/SANT DNA binding domain containing 3, transcript variant X4
Myb/SANT DNA binding domain containing 3, transcript variant X2
Myb/SANT DNA binding domain containing 3, transcript variant X1
Myb/SANT DNA binding domain containing 3, transcript variant X3
myb/SANT-like DNA-binding domain-containing protein 3
uncharacterized LOC125318475, transcript variant X2
uncharacterized LOC125318475, transcript variant X1
uncharacterized LOC125318475, transcript variant X3
uncharacterized protein LOC125318475 isoform X1
uncharacterized protein LOC125318475 isoform X2
testis expressed 10, transcript variant X1
testis expressed 10, transcript variant X4
testis expressed 10, transcript variant X2
testis expressed 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
endoplasmic reticulum resident protein 44
nuclear receptor subfamily 4 group A member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
protein transport protein Sec61 subunit beta
interferon alpha-inducible protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Golgi-associated plant pathogenesis-related protein 1
biogenesis of lysosomal organelles complex 1 subunit 4
biogenesis of lysosome-related organelles complex 1 subunit 4
par-6 family cell polarity regulator gamma
secretagogin, EF-hand calcium binding protein
capping protein regulator and myosin 1 linker 1, transcript variant X8
capping protein regulator and myosin 1 linker 1, transcript variant X4
capping protein regulator and myosin 1 linker 1, transcript variant X2
capping protein regulator and myosin 1 linker 1, transcript variant X6
capping protein regulator and myosin 1 linker 1, transcript variant X3
capping protein regulator and myosin 1 linker 1, transcript variant X5
capping protein regulator and myosin 1 linker 1, transcript variant X9
capping protein regulator and myosin 1 linker 1, transcript variant X7
capping protein regulator and myosin 1 linker 1, transcript variant X1
F-actin-uncapping protein LRRC16A isoform X8
F-actin-uncapping protein LRRC16A isoform X4
F-actin-uncapping protein LRRC16A isoform X2
F-actin-uncapping protein LRRC16A isoform X6
F-actin-uncapping protein LRRC16A isoform X3
F-actin-uncapping protein LRRC16A isoform X5
F-actin-uncapping protein LRRC16A isoform X9
F-actin-uncapping protein LRRC16A isoform X7
F-actin-uncapping protein LRRC16A isoform X1
RHO family interacting cell polarization regulator 2, transcript variant X3
RHO family interacting cell polarization regulator 2, transcript variant X5
rho family-interacting cell polarization regulator 2 isoform X3
rho family-interacting cell polarization regulator 2 isoform X5
RHO family interacting cell polarization regulator 2, transcript variant X1
rho family-interacting cell polarization regulator 2 isoform X1
RHO family interacting cell polarization regulator 2, transcript variant X6
RHO family interacting cell polarization regulator 2, transcript variant X2
RHO family interacting cell polarization regulator 2, transcript variant X4
rho family-interacting cell polarization regulator 2 isoform X6
rho family-interacting cell polarization regulator 2 isoform X2
rho family-interacting cell polarization regulator 2 isoform X4
myelin basic protein, transcript variant X1
myelin basic protein, transcript variant X2
zinc finger protein 236, transcript variant X3
zinc finger protein 236, transcript variant X2
zinc finger protein 236, transcript variant X1
zinc finger protein 236, transcript variant X6
zinc finger protein 236, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 236, transcript variant X4
zinc finger protein 516, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
zinc finger protein 516, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 516, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
teashirt zinc finger homeobox 1, transcript variant X1
teashirt zinc finger homeobox 1, transcript variant X2
prostaglandin reductase 3, transcript variant X1
prostaglandin reductase 3, transcript variant X3
prostaglandin reductase 3, transcript variant X4
prostaglandin reductase 3, transcript variant X5
prostaglandin reductase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 407
uncharacterized LOC125318430, transcript variant X3
uncharacterized LOC125318430, transcript variant X2
uncharacterized LOC125318430, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C18orf63 homolog
translocase of inner mitochondrial membrane 21
mitochondrial import inner membrane translocase subunit Tim21
neuropilin and tolloid like 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
neuropilin and tolloid like 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
neuropilin and tolloid like 1, transcript variant X10
neuropilin and tolloid like 1, transcript variant X8
neuropilin and tolloid like 1, transcript variant X9
neuropilin and tolloid like 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
neuropilin and tolloid like 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
neuropilin and tolloid like 1, transcript variant X3
neuropilin and tolloid like 1, transcript variant X5
neuropilin and tolloid like 1, transcript variant X4
neuropilin and tolloid like 1, transcript variant X7
neuropilin and tolloid like 1, transcript variant X2
neuropilin and tolloid like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
neuropilin and tolloid like 1, transcript variant X1
neuropilin and tolloid-like protein 1 isoform X1
neuropilin and tolloid-like protein 1 isoform X2
neuropilin and tolloid-like protein 1 isoform X3
neuropilin and tolloid-like protein 1 isoform X4
uncharacterized LOC125318568, transcript variant X2
uncharacterized LOC125318568, transcript variant X3
uncharacterized LOC125318568, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125318568, transcript variant X1
uncharacterized LOC125318568, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
suppressor of cytokine signaling 6, transcript variant X7
suppressor of cytokine signaling 6, transcript variant X10
suppressor of cytokine signaling 6, transcript variant X4
suppressor of cytokine signaling 6, transcript variant X8
suppressor of cytokine signaling 6, transcript variant X5
suppressor of cytokine signaling 6, transcript variant X6
suppressor of cytokine signaling 6, transcript variant X9
suppressor of cytokine signaling 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
suppressor of cytokine signaling 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
suppressor of cytokine signaling 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; deleted 3 bases in 3 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
docking protein 6, transcript variant X1
docking protein 6, transcript variant X2
coiled-coil domain-containing protein 102B
thioredoxin related transmembrane protein 3, transcript variant X1
thioredoxin related transmembrane protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
thioredoxin related transmembrane protein 3, transcript variant X3
protein disulfide-isomerase TMX3 isoform X1
protein disulfide-isomerase TMX3 isoform X2
protein disulfide-isomerase TMX3 isoform X3
protein-glutamine gamma-glutamyltransferase 5-like
uncharacterized LOC125318649, transcript variant X2
uncharacterized LOC125318649, transcript variant X4
uncharacterized LOC125318649, transcript variant X3
uncharacterized LOC125318649, transcript variant X1
uncharacterized LOC125318615, transcript variant X1
uncharacterized LOC125318615, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
melanocortin 5 receptor, transcript variant X1
melanocortin 5 receptor, transcript variant X2
family with sequence similarity 210 member A, transcript variant X5
family with sequence similarity 210 member A, transcript variant X2
family with sequence similarity 210 member A, transcript variant X1
family with sequence similarity 210 member A, transcript variant X3
family with sequence similarity 210 member A, transcript variant X4
low density lipoprotein receptor class A domain containing 4, transcript variant X2
low density lipoprotein receptor class A domain containing 4, transcript variant X1
low density lipoprotein receptor class A domain containing 4, transcript variant X5
low density lipoprotein receptor class A domain containing 4, transcript variant X4
low density lipoprotein receptor class A domain containing 4, transcript variant X3
low-density lipoprotein receptor class A domain-containing protein 4 isoform X2
low-density lipoprotein receptor class A domain-containing protein 4 isoform X1
low-density lipoprotein receptor class A domain-containing protein 4 isoform X4
low-density lipoprotein receptor class A domain-containing protein 4 isoform X3
low-density lipoprotein receptor class A domain-containing protein 4 isoform X5
protein tyrosine phosphatase non-receptor type 2, transcript variant X1
protein tyrosine phosphatase non-receptor type 2, transcript variant X2
tyrosine-protein phosphatase non-receptor type 2 isoform X2
tyrosine-protein phosphatase non-receptor type 2 isoform X1
centrosomal protein 76, transcript variant X1
centrosomal protein 76, transcript variant X2
centrosomal protein 76, transcript variant X3
centrosomal protein of 76 kDa isoform X1
centrosomal protein of 76 kDa isoform X2
spire type actin nucleation factor 1, transcript variant X1
spire type actin nucleation factor 1, transcript variant X3
spire type actin nucleation factor 1, transcript variant X2
spire type actin nucleation factor 1, transcript variant X6
spire type actin nucleation factor 1, transcript variant X4
spire type actin nucleation factor 1, transcript variant X5
PRELI domain containing 3A, transcript variant X1
PRELI domain containing protein 3A isoform X1
PRELI domain containing 3A, transcript variant X2
PRELI domain containing 3A, transcript variant X3
PRELI domain containing protein 3A isoform X2
AFG3 like matrix AAA peptidase subunit 2, transcript variant X1
AFG3 like matrix AAA peptidase subunit 2, transcript variant X2
AFG3 like matrix AAA peptidase subunit 2, transcript variant X3
cell death inducing DFFA like effector a, transcript variant X1
cell death inducing DFFA like effector a, transcript variant X2
metallophosphoesterase 1, transcript variant X3
metallophosphoesterase 1, transcript variant X2
metallophosphoesterase 1, transcript variant X8
metallophosphoesterase 1, transcript variant X4
metallophosphoesterase 1, transcript variant X5
metallophosphoesterase 1, transcript variant X7
metallophosphoesterase 1, transcript variant X1
metallophosphoesterase 1, transcript variant X6
G protein subunit alpha L, transcript variant X1
G protein subunit alpha L, transcript variant X2
G protein subunit alpha L, transcript variant X4
G protein subunit alpha L, transcript variant X3
guanine nucleotide-binding protein G(olf) subunit alpha isoform X1
guanine nucleotide-binding protein G(olf) subunit alpha isoform X2
guanine nucleotide-binding protein G(olf) subunit alpha isoform X3
uncharacterized LOC125318470, transcript variant X1
uncharacterized LOC125318470, transcript variant X2
piezo type mechanosensitive ion channel component 2, transcript variant X1
piezo type mechanosensitive ion channel component 2, transcript variant X2
piezo type mechanosensitive ion channel component 2, transcript variant X3
piezo-type mechanosensitive ion channel component 2 isoform X1
piezo-type mechanosensitive ion channel component 2 isoform X2
piezo-type mechanosensitive ion channel component 2 isoform X3
uncharacterized LOC125318533, transcript variant X2
uncharacterized LOC125318533, transcript variant X4
uncharacterized LOC125318533, transcript variant X3
uncharacterized LOC125318533, transcript variant X1
uncharacterized LOC125318534, transcript variant X1
uncharacterized LOC125318534, transcript variant X2
vesicle-associated membrane protein-associated protein A
RAB31, member RAS oncogene family, transcript variant X2
RAB31, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 4 regulatory subunit 1, transcript variant X1
protein phosphatase 4 regulatory subunit 1, transcript variant X9
protein phosphatase 4 regulatory subunit 1, transcript variant X4
protein phosphatase 4 regulatory subunit 1, transcript variant X3
protein phosphatase 4 regulatory subunit 1, transcript variant X6
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X8
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X4
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X6
protein phosphatase 4 regulatory subunit 1, transcript variant X10
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X9
protein phosphatase 4 regulatory subunit 1, transcript variant X2
protein phosphatase 4 regulatory subunit 1, transcript variant X5
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X5
protein phosphatase 4 regulatory subunit 1, transcript variant X7
protein phosphatase 4 regulatory subunit 1, transcript variant X8
protein phosphatase 4 regulatory subunit 1, transcript variant X12
protein phosphatase 4 regulatory subunit 1, transcript variant X11
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X7
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X10
ralA binding protein 1, transcript variant X1
ralA binding protein 1, transcript variant X2
ralA binding protein 1, transcript variant X3
twisted gastrulation BMP signaling modulator 1, transcript variant X1
twisted gastrulation BMP signaling modulator 1, transcript variant X2
ankyrin repeat domain 12, transcript variant X1
ankyrin repeat domain 12, transcript variant X2
ankyrin repeat domain-containing protein 12 isoform X1
ankyrin repeat domain-containing protein 12 isoform X2
uncharacterized LOC125318516, transcript variant X1
NADH:ubiquinone oxidoreductase core subunit V2
NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial
uncharacterized LOC125318516, transcript variant X2
microtubule crosslinking factor 1, transcript variant X2
microtubule crosslinking factor 1, transcript variant X1
microtubule crosslinking factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
protein tyrosine phosphatase receptor type M, transcript variant X9
protein tyrosine phosphatase receptor type M, transcript variant X4
protein tyrosine phosphatase receptor type M, transcript variant X2
protein tyrosine phosphatase receptor type M, transcript variant X11
protein tyrosine phosphatase receptor type M, transcript variant X10
protein tyrosine phosphatase receptor type M, transcript variant X8
protein tyrosine phosphatase receptor type M, transcript variant X7
protein tyrosine phosphatase receptor type M, transcript variant X6
protein tyrosine phosphatase receptor type M, transcript variant X5
protein tyrosine phosphatase receptor type M, transcript variant X3
protein tyrosine phosphatase receptor type M, transcript variant X1
receptor-type tyrosine-protein phosphatase mu isoform X11
receptor-type tyrosine-protein phosphatase mu isoform X10
receptor-type tyrosine-protein phosphatase mu isoform X8
receptor-type tyrosine-protein phosphatase mu isoform X7
receptor-type tyrosine-protein phosphatase mu isoform X6
receptor-type tyrosine-protein phosphatase mu isoform X5
receptor-type tyrosine-protein phosphatase mu isoform X3
receptor-type tyrosine-protein phosphatase mu isoform X9
receptor-type tyrosine-protein phosphatase mu isoform X4
receptor-type tyrosine-protein phosphatase mu isoform X2
receptor-type tyrosine-protein phosphatase mu isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 30
laminin subunit alpha 1, transcript variant X1
laminin subunit alpha 1, transcript variant X2
Rho GTPase activating protein 28, transcript variant X7
Rho GTPase activating protein 28, transcript variant X1
Rho GTPase activating protein 28, transcript variant X3
Rho GTPase activating protein 28, transcript variant X6
Rho GTPase activating protein 28, transcript variant X4
Rho GTPase activating protein 28, transcript variant X5
rho GTPase-activating protein 28 isoform X1
rho GTPase-activating protein 28 isoform X3
rho GTPase-activating protein 28 isoform X5
rho GTPase-activating protein 28 isoform X4
Rho GTPase activating protein 28, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
rho GTPase-activating protein 28 isoform X2
erythrocyte membrane protein band 4.1 like 3, transcript variant X10
erythrocyte membrane protein band 4.1 like 3, transcript variant X1
erythrocyte membrane protein band 4.1 like 3, transcript variant X7
erythrocyte membrane protein band 4.1 like 3, transcript variant X9
erythrocyte membrane protein band 4.1 like 3, transcript variant X8
erythrocyte membrane protein band 4.1 like 3, transcript variant X22
erythrocyte membrane protein band 4.1 like 3, transcript variant X25
erythrocyte membrane protein band 4.1 like 3, transcript variant X26
erythrocyte membrane protein band 4.1 like 3, transcript variant X29
erythrocyte membrane protein band 4.1 like 3, transcript variant X6
erythrocyte membrane protein band 4.1 like 3, transcript variant X27
erythrocyte membrane protein band 4.1 like 3, transcript variant X11
erythrocyte membrane protein band 4.1 like 3, transcript variant X15
erythrocyte membrane protein band 4.1 like 3, transcript variant X32
erythrocyte membrane protein band 4.1 like 3, transcript variant X14
erythrocyte membrane protein band 4.1 like 3, transcript variant X20
erythrocyte membrane protein band 4.1 like 3, transcript variant X16
erythrocyte membrane protein band 4.1 like 3, transcript variant X21
erythrocyte membrane protein band 4.1 like 3, transcript variant X5
erythrocyte membrane protein band 4.1 like 3, transcript variant X13
erythrocyte membrane protein band 4.1 like 3, transcript variant X19
erythrocyte membrane protein band 4.1 like 3, transcript variant X31
erythrocyte membrane protein band 4.1 like 3, transcript variant X34
erythrocyte membrane protein band 4.1 like 3, transcript variant X2
erythrocyte membrane protein band 4.1 like 3, transcript variant X24
erythrocyte membrane protein band 4.1 like 3, transcript variant X28
erythrocyte membrane protein band 4.1 like 3, transcript variant X12
erythrocyte membrane protein band 4.1 like 3, transcript variant X18
erythrocyte membrane protein band 4.1 like 3, transcript variant X23
erythrocyte membrane protein band 4.1 like 3, transcript variant X30
erythrocyte membrane protein band 4.1 like 3, transcript variant X17
erythrocyte membrane protein band 4.1 like 3, transcript variant X33
erythrocyte membrane protein band 4.1 like 3, transcript variant X35
erythrocyte membrane protein band 4.1 like 3, transcript variant X4
erythrocyte membrane protein band 4.1 like 3, transcript variant X3
zinc finger and BTB domain containing 14, transcript variant X1
zinc finger and BTB domain containing 14, transcript variant X2
zinc finger and BTB domain-containing protein 14
DLG associated protein 1, transcript variant X7
DLG associated protein 1, transcript variant X3
DLG associated protein 1, transcript variant X4
DLG associated protein 1, transcript variant X1
DLG associated protein 1, transcript variant X5
DLG associated protein 1, transcript variant X6
DLG associated protein 1, transcript variant X2
disks large-associated protein 1 isoform X1
disks large-associated protein 1 isoform X2
disks large-associated protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67% coverage of the annotated genomic feature by RNAseq alignments
TGFB induced factor homeobox 1, transcript variant X2
TGFB induced factor homeobox 1, transcript variant X4
TGFB induced factor homeobox 1, transcript variant X3
TGFB induced factor homeobox 1, transcript variant X1
TGFB induced factor homeobox 1, transcript variant X5
myosin regulatory light chain 2, smooth muscle minor isoform-like, transcript variant X1
myosin regulatory light chain 2, smooth muscle minor isoform-like, transcript variant X2
myosin regulatory light chain 2, smooth muscle minor isoform-like
myosin regulatory light chain 2, smooth muscle minor isoform, transcript variant X2
myosin regulatory light chain 2, smooth muscle minor isoform, transcript variant X1
myosin regulatory light chain 2, smooth muscle minor isoform isoform X1
myosin regulatory light chain 2, smooth muscle minor isoform isoform X2
uncharacterized LOC125318587, transcript variant X2
uncharacterized LOC125318587, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
phosphatidate phosphatase LPIN2 isoform X1
phosphatidate phosphatase LPIN2 isoform X3
phosphatidate phosphatase LPIN2 isoform X4
phosphatidate phosphatase LPIN2 isoform X2
structural maintenance of chromosomes flexible hinge domain containing 1
structural maintenance of chromosomes flexible hinge domain-containing protein 1
methyltransferase 4, N6-adenosine, transcript variant X5
methyltransferase 4, N6-adenosine, transcript variant X4
methyltransferase 4, N6-adenosine, transcript variant X1
methyltransferase 4, N6-adenosine, transcript variant X2
methyltransferase 4, N6-adenosine, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
methyltransferase 4, N6-adenosine, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
methyltransferase 4, N6-adenosine, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
methyltransferase 4, N6-adenosine, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N(6)-adenine-specific methyltransferase METTL4 isoform X1
N(6)-adenine-specific methyltransferase METTL4 isoform X2
N(6)-adenine-specific methyltransferase METTL4 isoform X5
N(6)-adenine-specific methyltransferase METTL4 isoform X6
N(6)-adenine-specific methyltransferase METTL4 isoform X7
N(6)-adenine-specific methyltransferase METTL4 isoform X3
N(6)-adenine-specific methyltransferase METTL4 isoform X4
adenylate cyclase activating polypeptide 1, transcript variant X3
adenylate cyclase activating polypeptide 1, transcript variant X2
adenylate cyclase activating polypeptide 1, transcript variant X1
pituitary adenylate cyclase-activating polypeptide
YES proto-oncogene 1, Src family tyrosine kinase
ubiquitin carboxyl-terminal hydrolase 14
Rho associated coiled-coil containing protein kinase 1, transcript variant X4
Rho associated coiled-coil containing protein kinase 1, transcript variant X3
Rho associated coiled-coil containing protein kinase 1, transcript variant X2
Rho associated coiled-coil containing protein kinase 1, transcript variant X1
rho-associated protein kinase 1 isoform X2
rho-associated protein kinase 1 isoform X3
rho-associated protein kinase 1 isoform X1
Rho associated coiled-coil containing protein kinase 1, transcript variant X5
Rho associated coiled-coil containing protein kinase 1, transcript variant X7
Rho associated coiled-coil containing protein kinase 1, transcript variant X6
rho-associated protein kinase 1 isoform X4
GREB1 like retinoic acid receptor coactivator, transcript variant X1
GREB1 like retinoic acid receptor coactivator, transcript variant X2
GREB1 like retinoic acid receptor coactivator, transcript variant X4
GREB1 like retinoic acid receptor coactivator, transcript variant X7
GREB1 like retinoic acid receptor coactivator, transcript variant X3
GREB1 like retinoic acid receptor coactivator, transcript variant X5
GREB1 like retinoic acid receptor coactivator, transcript variant X6
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X1
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
abhydrolase domain containing 3, phospholipase, transcript variant X1
abhydrolase domain containing 3, phospholipase, transcript variant X2
MIB E3 ubiquitin protein ligase 1, transcript variant X1
MIB E3 ubiquitin protein ligase 1, transcript variant X2
MIB E3 ubiquitin protein ligase 1, transcript variant X3
E3 ubiquitin-protein ligase MIB1 isoform X1
E3 ubiquitin-protein ligase MIB1 isoform X2
E3 ubiquitin-protein ligase MIB1 isoform X3
GATA binding protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GATA binding protein 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GATA binding protein 6, transcript variant X1
RB binding protein 8, endonuclease, transcript variant X2
RB binding protein 8, endonuclease, transcript variant X3
RB binding protein 8, endonuclease, transcript variant X4
RB binding protein 8, endonuclease, transcript variant X1
Cdk5 and Abl enzyme substrate 1, transcript variant X1
CDK5 and ABL1 enzyme substrate 1 isoform X1
Cdk5 and Abl enzyme substrate 1, transcript variant X2
CDK5 and ABL1 enzyme substrate 1 isoform X2
transmembrane protein 241, transcript variant X2
transmembrane protein 241, transcript variant X1
serine/threonine-protein kinase RIO3 isoform X1
serine/threonine-protein kinase RIO3 isoform X2
NPC intracellular cholesterol transporter 1
ankyrin repeat domain 29, transcript variant X3
ankyrin repeat domain 29, transcript variant X2
ankyrin repeat domain 29, transcript variant X1
ankyrin repeat domain-containing protein 29 isoform X2
ankyrin repeat domain-containing protein 29 isoform X1
laminin subunit alpha 3, transcript variant X1
laminin subunit alpha 3, transcript variant X2
uncharacterized LOC125318541, transcript variant X2
uncharacterized LOC125318541, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
oxysterol binding protein like 1A, transcript variant X1
oxysterol binding protein like 1A, transcript variant X4
oxysterol binding protein like 1A, transcript variant X2
oxysterol binding protein like 1A, transcript variant X3
oxysterol-binding protein-related protein 1 isoform X1
oxysterol-binding protein-related protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 521, transcript variant X1
zinc finger protein 521, transcript variant X9
zinc finger protein 521, transcript variant X2
zinc finger protein 521, transcript variant X8
zinc finger protein 521, transcript variant X4
zinc finger protein 521, transcript variant X3
zinc finger protein 521, transcript variant X6
zinc finger protein 521, transcript variant X5
zinc finger protein 521, transcript variant X12
zinc finger protein 521, transcript variant X10
zinc finger protein 521, transcript variant X11
zinc finger protein 521, transcript variant X7
SS18 subunit of BAF chromatin remodeling complex, transcript variant X4
SS18 subunit of BAF chromatin remodeling complex, transcript variant X1
SS18 subunit of BAF chromatin remodeling complex, transcript variant X3
SS18 subunit of BAF chromatin remodeling complex, transcript variant X2
TATA-box binding protein associated factor 4b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4B
potassium channel tetramerization domain containing 1, transcript variant X1
potassium channel tetramerization domain containing 1, transcript variant X3
potassium channel tetramerization domain containing 1, transcript variant X2
potassium channel tetramerization domain containing 1, transcript variant X4
BTB/POZ domain-containing protein KCTD1 isoform X3
BTB/POZ domain-containing protein KCTD1 isoform X1
BTB/POZ domain-containing protein KCTD1 isoform X4
BTB/POZ domain-containing protein KCTD1 isoform X2
carbohydrate sulfotransferase 9, transcript variant X2
carbohydrate sulfotransferase 9, transcript variant X1
carbohydrate sulfotransferase 9, transcript variant X4
carbohydrate sulfotransferase 9, transcript variant X3
carbohydrate sulfotransferase 9 isoform X1
carbohydrate sulfotransferase 9 isoform X2
carbohydrate sulfotransferase 9 isoform X3